Luuk van Dijk
Hoofd Techniek/Wetenschap/O&O bij KUROS BIOSCIENCES AG
Oorsprong van het eerstegraads netwerk van Luuk van Dijk
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 32 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Luuk van Dijk via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| AFFIMED N.V. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Xpand Biotechnology BV
 Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Biotechnology | Chief Executive Officer Founder | |
Kuros Biosciences AG
 Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosciences AG is a Swiss company that specializes in developing innovative solutions for targeted and controlled bone healing. The private company is based in Schlieren, Switzerland. The company's mission is to eliminate non-unions and improve patient rehabilitation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Twente | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Kuros Therapeutics AG | Chief Executive Officer Founder | ||
| IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Zurich | College/University | Undergraduate Degree Masters Business Admin | |
Spinal Elements, Inc.
 Spinal Elements, Inc. Medical SpecialtiesHealth Technology Spinal Elements, Inc. designs, develops, manufactures and markets medical devices used in spinal surgical procedures. It offers cervical, lumbar, biologics and thoracolumbar products. The company was founded by Jason Blain and Steve McGowan in April 2017 and is headquartered in Carlsbad, CA. | Medical Specialties | Chairman Chief Executive Officer | |
| University of London | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Leiden | College/University | Doctorate Degree Undergraduate Degree | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Masters Business Admin Undergraduate Degree | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Materiomics BV
 Materiomics BV BiotechnologyHealth Technology Materiomics BV provides TopoChip technology to identify the surface of devices. It analyzes selection of material, cell type, conditions and desired biological response. The company was founded by Jan de Boer and Frank-Jan Van Der Velden and is headquartered in Maastricht, the Netherlands. | Biotechnology | Chief Executive Officer | |
Krüger & Partners
 Krüger & Partners Miscellaneous Commercial ServicesCommercial Services Krüger & Partners is a management consulting firm based in Rotterdam, Netherlands. The Dutch company provides management consulting services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Queen Mary University of London | College/University | Corporate Officer/Principal | |
Cellcotec BV
 Cellcotec BV Packaged SoftwareTechnology Services Cellcotec BV develops interaction technology for medical devices. The Dutch company was founded by Frank-Jan van der Velden, Jeanine Hendriks, Jens Riesle. | Packaged Software | Founder | |
| Scinus Cell Expansion BV | Founder | ||
Polyganics BV
 Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Chairman | |
| Delft University of Technology | College/University | Masters Business Admin | |
| Rotterdam School of Management | College/University | Undergraduate Degree | |
IsoTis NV
 IsoTis NV BiotechnologyHealth Technology IsoTis NV manufactures, markets and sells a range of bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Bilthoven, the Netherlands | Biotechnology | Founder | |
| The European Society for Biomaterials | Treasurer | ||
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Consultant / Advisor | |
| The Institute For Technology-Inspired Regenerative Medicine | College/University | Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
IsoTis SA
 IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MEDARTIS HOLDING AG | Medical Specialties | Director/Board Member | |
DiaMedCare GmbH
 DiaMedCare GmbH Miscellaneous Commercial ServicesCommercial Services DiaMedCare GmbH provides business consulting services. The private company is based in Munich, Germany. The German company was founded in 2016 by Gerhard Ries. The CEO is Dimitrios Dimitrakopoulos. | Miscellaneous Commercial Services | Founder | |
NeoPrediX AG
 NeoPrediX AG Packaged SoftwareTechnology Services NeoPrediX AG is a Swiss young company in the medical technology software field. NeoPrediX is based in Basel, Switzerland. The company transforms medical data into intelligent predictions to support clinical decisions. | Packaged Software | Chairman | |
| University of Leeds | College/University | Undergraduate Degree | |
| Henley Management College | College/University | Masters Business Admin |
Statistieken
Internationaal
| Nederland | 18 |
| Zwitserland | 12 |
| Verenigde Staten | 9 |
| Duitsland | 8 |
| Verenigd Koninkrijk | 7 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 125 |
| Corporate Officer/Principal | 66 |
| Chairman | 30 |
| Chief Executive Officer | 28 |
| Chief Tech/Sci/R&D Officer | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Gerhard Ries | 27 |
| Vincent Ossipow | 22 |
| Harry Welten | 22 |
| Dominik Ellenrieder | 20 |
| Giacomo di Nepi | 16 |
| Scott P. Bruder | 16 |
| James Ryaby | 13 |
| Clemens A. van Blitterswijk | 12 |
| Christian Itin | 12 |
| Leanna Caron | 12 |
| Oliver Walker | 11 |
| Jason M. Hannon | 10 |
| Michael Grau | 10 |
| Didier Cowling | 10 |
- Beurs
- Insiders
- Luuk van Dijk
- Bedrijfsconnecties
